Sign in

    Veeva Systems Inc (VEEV)

    You might also like

    Business Description

    Veeva Systems Inc. is a leading provider of industry cloud solutions specifically designed for the global life sciences industry. The company offers cloud software, data, analytics, professional services, and business consulting to help life sciences companies develop and bring products to market more efficiently, market and sell more effectively, and maintain compliance with government regulations . Veeva's solutions are organized into major product categories that address various business functions from research and development to commercialization .

    1. Commercial Solutions - Includes Veeva Commercial Cloud, Veeva Data Cloud, and Veeva Claims solutions, helping life sciences companies engage with healthcare professionals and organizations, and execute effective marketing campaigns .

      • Veeva Commercial Cloud - Facilitates intelligent engagement across multiple communication channels.
      • Veeva Data Cloud - Provides data management and analytics capabilities.
      • Veeva Claims - Supports compliance and marketing claims management.

    2. R&D Solutions - Comprises Veeva Development Cloud, Veeva RegulatoryOne, and Veeva QualityOne solutions, streamlining product development processes and maintaining regulatory compliance .

      • Veeva Development Cloud - Enhances clinical, regulatory, quality, and safety functions.
      • Veeva RegulatoryOne - Manages regulatory documents and trial information.
      • Veeva QualityOne - Ensures quality management throughout the product lifecycle.

    Key Metrics

    View all financials →

    Executive Team

    NamePositionStart DateShort Bio
    Peter P. GassnerChief Executive Officer and Director2007Peter P. Gassner is the CEO and Director of Veeva Systems Inc. since its founding in 2007. He has extensive expertise in the software industry, having previously served as SVP of Technology at Salesforce.com and Chief Architect at PeopleSoft .
    Thomas D. SchwengerPresident and Chief Customer OfficerApril 1, 2024Thomas D. Schwenger has been President and Chief Customer Officer since April 1, 2024. He joined Veeva in 2019 and previously served as President and COO. Before Veeva, he had a long tenure at Accenture plc .
    Tim CabralInterim Chief Financial OfficerApril 1, 2024Tim Cabral served as Interim CFO from April 1, 2024, until September 16, 2024. He was Veeva's CFO from 2010 to 2020 and has been on the board since 2022. He has held leadership roles at PeopleSoft and Chiron Corp .
    E. Nitsa ZuppasPresident and Chief of StaffApril 1, 2024E. Nitsa Zuppas has been President and Chief of Staff since April 1, 2024. She was previously Veeva's CMO from 2013 to 2024 and held executive roles at First Virtual Group and Siebel Systems .
    Stacey EpsteinChief Marketing OfficerApril 1, 2024Stacey Epstein was appointed CMO on April 1, 2024. She was previously CMO at Freshworks Inc. and held roles at ServiceMax, including Chief Marketing and Customer Experience Officer .
    Alan V. MateoExecutive Vice President, Global SalesApril 2015Alan V. Mateo has been EVP, Global Sales since April 2015. He previously held executive roles at Medidata Solutions and PeopleSoft. He is set to retire on April 30, 2024, transitioning to a part-time advisor role .
    Jonathan (Josh) FaddisSenior Vice President, General Counsel, and SecretarySeptember 2012Jonathan (Josh) Faddis has been SVP, General Counsel, and Secretary since September 2012. He previously worked at Taleo Corporation and practiced law at Fulbright & Jaworski LLP .
    Brian Van WagenerChief Financial OfficerSeptember 16, 2024Brian Van Wagener became CFO on September 16, 2024. He was previously EVP, Finance at Veeva and held roles at BetterUp and Frontier Communications. He has over 20 years of experience in technology, healthcare, and life sciences sectors .

    Questions to Ask Management

    1. With the migration from Veeva CRM on Salesforce to Vault CRM progressing slowly and significant margin improvements spread out until 2030, can you provide more precise timelines on when investors can expect to see a noticeable impact on gross margins due to reduced Salesforce royalties?

    2. Despite announcing your pivot toward horizontal enterprise applications, you've yet to share a concrete product strategy or timeline; when can we expect more detailed information on the specific application areas or customer segments you plan to target, and how will this diversification impact your core life sciences focus?

    3. Given that clinical trial starts have been increasing globally over the past two quarters, how is Veeva leveraging this trend within your Development Cloud offerings, and are you seeing a corresponding uptick in demand that aligns with these industry metrics?

    4. You mentioned having only marginally better visibility into fiscal 2026 compared to prior years; given the uncertain macro environment, what factors are limiting your ability to forecast more confidently, and how are you addressing potential risks to maintain your growth trajectory?

    5. With CRO revenue remaining approximately 5% of total revenue and not materially changing, what strategies are you implementing to accelerate growth in this segment, and how critical do you view CRO partnerships to your long-term growth plans?